Fagan, Andrew

A randomized clinical trial of fecal microbiota transplant for alcohol use disorder

Bajaj, J. S., Gavis, E. A., Fagan, A., Wade, J. B., Thacker, L. R., Fuchs, M., Patel, S., Davis, B., Meador, J., Puri, P., et al. (2021) · Hepatology

Gut microbiota and healthAlcohol Consumption and Health Effects

Cited by 262

Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

Acharya, C., Betrapally, N. S., Gillevet, P. M., Sterling, R. K., Akbarali, H., White, M. B., Ganapathy, D., Fagan, A., Sikaroodi, M., & Bajaj, J. S. (2017) · Alimentary Pharmacology & Therapeutics

Liver Disease and TransplantationGut microbiota and health

Cited by 175

Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease

Riva, A., Patel, V., Kurioka, A., Jeffery, H. C., Wright, G., Tarff, S., Shawcross, D., Ryan, J. M., Evans, A., Azarian, S., et al. (2018) · Gut

Alcohol Consumption and Health EffectsT-cell and B-cell Immunology

Cited by 150

Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort

Bajaj, J. S., Idilman, R., Mabudian, L., Hood, M., Fagan, A., Turan, D., White, M. B., Karakaya, F., Wang, J., Atalay, R., et al. (2018) · Hepatology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 125

QuickStroop predicts time to development of overt hepatic encephalopathy and related hospitalizations in patients with cirrhosis

Kanagalingam, G., Park, D., Badal, B. D., Fagan, A., Thacker, L. R., & Bajaj, J. S. (2024) · Clinical Gastroenterology and Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 12